Higher dose requirements with insulin detemir in type 2 diabetes--three cases and a review of the literature

Sanne G. H. A. Swinnen; J. Hans DeVries

doi:10.1016/j.diabres.2009.06.013

Higher dose requirements with insulin detemir in type 2 diabetes--three cases and a review of the literature

Sanne G. H. A. Swinnen
, J. Hans DeVries

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

We report on three type 2 diabetic patients whose daily basal insulin dose requirements were substantially reduced after switching from insulin detemir to insulin glargine. Meta-analysis of three randomised trials of basal insulin initiation confirmed this increased insulin detemir dose requirement in type 2 patients. Potential explanations are discussed

Original language	English
Pages (from-to)	e24-e26
Journal	Diabetes research and clinical practice
Volume	84
Issue number	2
DOIs	https://doi.org/10.1016/j.diabres.2009.06.013
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.diabres.2009.06.013

Cite this

@article{915fc51992e34c7aaad8d127aedc7605,

title = "Higher dose requirements with insulin detemir in type 2 diabetes--three cases and a review of the literature",

abstract = "We report on three type 2 diabetic patients whose daily basal insulin dose requirements were substantially reduced after switching from insulin detemir to insulin glargine. Meta-analysis of three randomised trials of basal insulin initiation confirmed this increased insulin detemir dose requirement in type 2 patients. Potential explanations are discussed",

author = "Swinnen, \{Sanne G. H. A.\} and DeVries, \{J. Hans\}",

year = "2009",

doi = "10.1016/j.diabres.2009.06.013",

language = "English",

volume = "84",

pages = "e24--e26",

journal = "Diabetes research and clinical practice",

issn = "0168-8227",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Higher dose requirements with insulin detemir in type 2 diabetes--three cases and a review of the literature

AU - Swinnen, Sanne G. H. A.

AU - DeVries, J. Hans

PY - 2009

Y1 - 2009

N2 - We report on three type 2 diabetic patients whose daily basal insulin dose requirements were substantially reduced after switching from insulin detemir to insulin glargine. Meta-analysis of three randomised trials of basal insulin initiation confirmed this increased insulin detemir dose requirement in type 2 patients. Potential explanations are discussed

AB - We report on three type 2 diabetic patients whose daily basal insulin dose requirements were substantially reduced after switching from insulin detemir to insulin glargine. Meta-analysis of three randomised trials of basal insulin initiation confirmed this increased insulin detemir dose requirement in type 2 patients. Potential explanations are discussed

U2 - 10.1016/j.diabres.2009.06.013

DO - 10.1016/j.diabres.2009.06.013

M3 - Comment/Letter to the editor

C2 - 19251336

SN - 0168-8227

VL - 84

SP - e24-e26

JO - Diabetes research and clinical practice

JF - Diabetes research and clinical practice

IS - 2

ER -

Higher dose requirements with insulin detemir in type 2 diabetes--three cases and a review of the literature

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this